Clinical Trial Update: Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a probiotic treatment for irritable bowel syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Probiotic formulation (unspecified) (probiotic)

Snippet

Sponsor: Next Gen Pharma India Pvt. Ltd. | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: WITHDRAWN